A recent study by the researchers in the U.S. found that the FDA-approved medicine Sildenafil, popularly known as Viagra, might soon be used to treat Alzheimer's risk.
The first revolutionary drug to slow Alzheimer s could be approved within days, but some doctors are concerned about rare cases of serious side effects.
(Bloomberg) Biogen Inc. fell the most in two years as its latest foray into Alzheimer’s disease got off to a slow start, suggesting a long road to growth for the biotechnology giant.Most Read from BloombergMusk Says Putin Can’t Lose in Ukraine, Opposes Senate BillS&P 500 Set for Worst CPI Day Since September 2022: Markets WrapPutin Seeks Revenge on a World Order He Once Wanted to JoinRetail Traders Are Losing Billions in India’s Booming Options MarketTrump Asks Supreme Court to Keep DC Electi
Biogen discontinues Alzheimer s drug Aduhelm, which has a lack of coverage amid efficacy concerns, after weighing its finances. It is redirecting efforts to Leqembi, approved by FDA in 2023.